{'fraction_non_alphanumeric': 0.01636904761904762, 'fraction_numerical': 0.0, 'mean_word_length': 6.556179775280899, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Reflectance confocal microscopy can differentiate dermoscopic white dots of the scalp between sweat gland ducts or follicular infundibulum

significantly improves progression-free and overall survival in patients with glioblastoma multiforme. Temozolomide, an oral alkylating agent, is a derivative of dacarbazine and undergoes rapid chemical conversion to the active compound monomethyl triazeno imidazole carboxamide. Temozolomide exhibits antineoplastic activity by interfering with DNA replication. However, patients treated with long-term corticosteroid therapy and chemotherapy are at increased risk of developing opportunistic infections, especially when they additionally develop lymphopenia commonly associated with temozolomide. They also may be susceptible to infections with cytomegalovirus, Cryptococcus neoformans and Salmonella species. Besides a brain abscess with Listeria monocytogenes, Pneumocystis jiroveci pneumonia and cutaneous Kaposi sarcoma have been observed in a patient undergoing treatment with temozolomide. In summary, this is the first case of R. mucilaginosa folliculitis, probably facilitated by immunosuppression with temozolomide, in a rare syndrome, LFS. Rhodotorula mucilaginosa can be a significant, recalcitrant pathogen in immunocompromised patients and prompt antimycotic treatment should be initiated.